U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
144211144211Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological ParametersCompletedNo Results AvailableObesityBehavioral: Lifestyle interventionhttps://ClinicalTrials.gov/show/NCT00674544
144212144212Detection of Enterovirus RNA in Atheromatous LesionsCompletedNo Results AvailableArteriosclerosisProcedure: Artery resectionhttps://ClinicalTrials.gov/show/NCT00674531
144213144213Changing Healthy Outcomes In Clinic EnvironmentsActive, not recruitingNo Results AvailableObesity|Physical Inactivity|DiabetesBehavioral: One on one counseling|Behavioral: Group/team - based health education|Behavioral: PACE physician counselinghttps://ClinicalTrials.gov/show/NCT00674518
144214144214Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery StenosisActive, not recruitingNo Results AvailableRenal Stenting in the Treatment of Pts w/a High Grade Ostial Atherosclerotic Renal Lesion(s).Device: Lumen Biomedical FiberNet Embolic Protection Systemhttps://ClinicalTrials.gov/show/NCT00674505
144215144215Hepatitis C Virus (HCV) Treatment Completion or WithdrawalCompletedHas ResultsHepatitis Chttps://ClinicalTrials.gov/show/NCT00674492
144216144216INCB018424 in Patients With Advanced Hematologic MalignanciesActive, not recruitingNo Results AvailableAcute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome|Chronic Myelogenous LeukemiaDrug: INCB018424https://ClinicalTrials.gov/show/NCT00674479
144217144217A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin MonotherapyCompletedNo Results AvailableType 2 Diabetes MellitusDrug: 1.5 mg or 2.0 mg CJC-1134-PC|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00674466
144218144218The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine EvaluationCompletedNo Results AvailableBone LossDrug: Lasofoxifene|Other: Placebohttps://ClinicalTrials.gov/show/NCT00674453
144219144219Utility of [F-18] fluoroDOPA for Neonatal HyperinsulinismActive, not recruitingNo Results AvailableCongenital Hyperinsulinism|Hyperinsulinism|Persistent Hyperinsulinemic Hypoglycemia of Infancy|CHI|PHHIDrug: F-DOPA|Radiation: PET scanhttps://ClinicalTrials.gov/show/NCT00674440
144220144220Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell TransplantTerminatedNo Results AvailableChronic Myelogenous Leukemia|Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma|Hodgkin's Disease|Multiple Myeloma|Chronic Lymphocytic LeukemiaBiological: CD3/CD28 Activated T cells|Biological: CD3/CD28 Activated T cellshttps://ClinicalTrials.gov/show/NCT00674427
144221144221Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By SurgeryTerminatedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: everolimus|Procedure: therapeutic conventional surgeryhttps://ClinicalTrials.gov/show/NCT00674414
144222144222Radiofrequency Ablation of Drivers of Atrial FibrillationCompletedNo Results AvailableAtrial FibrillationProcedure: Radiofrequency catheter ablationhttps://ClinicalTrials.gov/show/NCT00674401
144223144223The Pediatric Anesthesia Quality Improvement ProjectRecruitingNo Results AvailableSurgery|Anesthesia|Childrenhttps://ClinicalTrials.gov/show/NCT00674388
144224144224Risk Score Alerts for Chest Pain CareCompletedNo Results AvailableChest Pain|Acute Myocardial InfarctionOther: Electronic risk alertshttps://ClinicalTrials.gov/show/NCT00674375
144225144225Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedHas ResultsRheumatoid ArthritisBiological: Certolizumab pegol|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00674362
144226144226Screening of Biomarkers on Endometrial CancersRecruitingNo Results AvailableEndometrial CancersProcedure: surgeryhttps://ClinicalTrials.gov/show/NCT00674349
144227144227Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge StudyCompletedNo Results AvailableHealthyProcedure: High Hydrostatic Pressure Processinghttps://ClinicalTrials.gov/show/NCT00674336
144228144228Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal VasculopathyCompletedHas ResultsPolypoidal Choroidal VasculopathyDrug: Verteporfin Photodynamic Therapy|Drug: Ranibizumabhttps://ClinicalTrials.gov/show/NCT00674323
144229144229A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNo Results AvailableParkinson's Disease|Restless Leg SyndromeDrug: Ropinirole Hydrochloridehttps://ClinicalTrials.gov/show/NCT00674310
144230144230Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsActive, not recruitingNo Results AvailableAntiphospholipid SyndromeDrug: Fluvastatinhttps://ClinicalTrials.gov/show/NCT00674297
144231144231Adrenal Exhaustion Syndrome in Critically Ill Patients Without ImprovementCompletedNo Results AvailableSurvivalhttps://ClinicalTrials.gov/show/NCT00674284
144232144232Immune Profile and Complication Risk in Type 2 DiabetesActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT00674271
144233144233Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung CancerRecruitingNo Results AvailableNon Small Cell Lung CancerBiological: URLC10, TTK and KOC1https://ClinicalTrials.gov/show/NCT00674258
144234144234Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.CompletedNo Results AvailableGastroesophageal Reflux DiseaseDrug: Pantoprazole|Drug: Pantoprazole|Drug: placebohttps://ClinicalTrials.gov/show/NCT00674245
144235144235Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical TreatmentCompletedNo Results AvailableIncomplete AbortionDrug: 600 mcg misoprostol|Procedure: Surgical treatmenthttps://ClinicalTrials.gov/show/NCT00674232
144236144236Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety DisorderCompletedNo Results AvailableOCD|Anxiety DisorderDrug: Namenda (Memantine)https://ClinicalTrials.gov/show/NCT00674219
144237144237A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerTerminatedHas ResultsBreast CancerDrug: Gemcitabine|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00674206
144238144238Evaluating Dactinomycin and Vincristine in Young Patients With CancerActive, not recruitingNo Results AvailableChildhood Acute Lymphoblastic Leukemia|Childhood Rhabdomyosarcoma|Childhood Soft Tissue Sarcoma|Ewing Sarcoma|Ewing Sarcoma of Bone|Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)|Unspecified Childhood Solid Tumor, Protocol Specific|Wilms Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00674193
144239144239Data Analysis of a Managed Care Weight Reduction TrialActive, not recruitingNo Results AvailableOverweight|ObesityBehavioral: Workbook|Behavioral: Computer Intervention|Behavioral: Staff Consultationhttps://ClinicalTrials.gov/show/NCT00674180
144240144240The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaActive, not recruitingNo Results AvailableGastric CancerDrug: Docetaxel|Drug: Cisplatin|Drug: Capecitabinehttps://ClinicalTrials.gov/show/NCT00674167

* Görseller ve İçerik tekif hakkına sahip olabilir